Switch to:
GuruFocus has detected 2 Warning Signs with Array BioPharma Inc $ARRY.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Array BioPharma Inc (NAS:ARRY)
EV-to-EBITDA
-13.69 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Array BioPharma Inc's enterprise value is $1,349.2 Mil. Array BioPharma Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2017 was $-98.5 Mil. Therefore, Array BioPharma Inc's EV/EBITDA ratio for today is -13.69.

ARRY' s EV-to-EBITDA Range Over the Past 10 Years
Min: -76.5   Max: 165.9
Current: -13.67

-76.5
165.9

During the past 13 years, the highest EV/EBITDA Ratio of Array BioPharma Inc was 165.90. The lowest was -76.50. And the median was -6.50.

ARRY's EV-to-EBITDA is ranked lower than
99.99% of the 466 Companies
in the Global Biotechnology industry.

( Industry Median: 17.12 vs. ARRY: -13.67 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Array BioPharma Inc's stock price is $8.34. Array BioPharma Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2017 was $-0.73. Therefore, Array BioPharma Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Array BioPharma Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=1349.225/-98.527
=-13.69

Array BioPharma Inc's current Enterprise Value is $1,349.2 Mil.
Array BioPharma Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2017 was -21.981 (Jun. 2016 ) + -25.154 (Sep. 2016 ) + -19.698 (Dec. 2016 ) + -31.694 (Mar. 2017 ) = $-98.5 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Array BioPharma Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=8.34/-0.73
=

Array BioPharma Inc's share price for today is $8.34.
Array BioPharma Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2017 was -0.18 (Jun. 2016 ) + -0.2 (Sep. 2016 ) + -0.14 (Dec. 2016 ) + -0.21 (Mar. 2017 ) = $-0.73.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Array BioPharma Inc Annual Data

Jun07Jun08Jun09Jun10Jun11Jun12Jun13Jun14Jun15Jun16
ev2ebitda -7.71-2.12-1.74-2.95-5.58-48.01-11.25-8.3340.89-6.39

Array BioPharma Inc Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
ev2ebitda -8.23124.1940.8920.1743.40-6.17-6.39-11.44-16.210.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK